Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002971 · ClinicalTrials.gov registry record
CONNEQT Pulse Validation Study
A clinical trial, sponsored by Mount Carmel Health System.
- Terminated
- Registry status
- 41
- Enrollment target
NCT06002971 is a clinical trial that was terminated before completion, run by Mount Carmel Health System. The registered enrollment target is 41 participants.
The verdict
NCT06002971 was terminated before completion, sponsored by Mount Carmel Health System.
- TERMINATED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the accuracy of the CONNEQT Pulse blood pressure monitoring system for the measurement of blood pressure as compared to a gold standard, auscultatory sphygmomanometer in a pregnant population.
Interventions
- DEVICE Blood pressure measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2025-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06002971
The ClinicalTrials.gov registry entry for NCT06002971 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mount Carmel Health System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood pressure measurement is the first listed.
NCT06002971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06002971 about?
NCT06002971 is a clinical study titled "CONNEQT Pulse Validation Study". The purpose of this study is to validate the accuracy of the CONNEQT Pulse blood pressure monitoring system for the measurement of blood pressure as compared to a gold standard, auscultatory sphygmomanometer in a pregnant population.
What is the current status of trial NCT06002971?
This trial is currently terminated. The enrollment target is 41 participants. The study started on 2023-08-21. Estimated completion is 2025-06-03.
What interventions are being tested in trial NCT06002971?
The interventions under investigation include: Blood pressure measurement (DEVICE).
Who is sponsoring clinical trial NCT06002971?
This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.